T1	Premise 48 172	65-year-old woman with no comorbidities, undergoing left breast-conserving surgery with selective sentinel lymph node biopsy
T2	Premise 174 381	The pathological anatomy of the specimen shows an infiltrating ductal carcinoma grade III of 11 mm, two negative sentinel nodes, estrogen receptors: 0%, progesterone receptors: 0%, Ki 67: 70%, HER2: negative
T3	Premise 383 414	The extension study is negative
T4	Claim 448 526	Chemotherapy based on anthracyclines and taxanes, radiotherapy and trastuzumab
T5	Claim 531 607	Chemotherapy based on anthracyclines and taxanes, radiotherapy and tamoxifen
T6	Claim 612 678	Chemotherapy based on anthracyclines and taxanes, and radiotherapy
T7	Claim 683 798	Chemotherapy based on anthracyclines and taxanes, radiotherapy and aromatase inhibitors, since it is postmenopausal
T8	Claim 825 889	Typical question, conservative surgery implies radiate, for sure
T9	Premise 891 965	High grade, and no hormone receptors or her2 (the dreaded triple negative)
T10	Claim 1120 1204	That is why today, anthracyclines (does not suffer from heart) and taxanes before RT
R1	Support Ent1:T10 Ent2:T6	
T11	Claim 967 1118	I was there when there were no taxanes or herceptin and I was in the trials that showed that more and more are being cured, unfortunately still not all
R2	Support Ent1:T9 Ent2:T10	
R3	Support Ent1:T11 Ent2:T10	
T12	Treatment 448 526	Chemotherapy based on anthracyclines and taxanes, radiotherapy and trastuzumab
T13	Treatment 531 579	Chemotherapy based on anthracyclines and taxanes
T14	Treatment 612 660	Chemotherapy based on anthracyclines and taxanes
T15	Treatment 666 678	radiotherapy
T16	Treatment 581 593	radiotherapy
T17	Treatment 598 607	tamoxifen
T18	Treatment 683 731	Chemotherapy based on anthracyclines and taxanes
T19	Treatment 733 745	radiotherapy
T20	Treatment 750 770	aromatase inhibitors
T21	Marker 772 777	since
